AngioDynamics stock price target raised to $18 from $17 at Canaccord Genuity
PositiveFinancial Markets

AngioDynamics has received a boost as Canaccord Genuity has raised its stock price target from $17 to $18. This adjustment reflects growing confidence in the company's performance and potential for growth, which is great news for investors. A higher price target often indicates that analysts believe the company is on a positive trajectory, making it an attractive option in the market.
— Curated by the World Pulse Now AI Editorial System